Cargando…
Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily
An important goal of effective rosacea treatment is to maximize the duration of remission. This was a two‐part study. Part 1 was a multicenter, open‐label, 12‐week study in which adults with moderate or severe inflammatory lesions (papules and pustules) of rosacea received subantibiotic dose oral do...
Autores principales: | Del Rosso, James Q., Brantman, Sam, Baldwin, Hilary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285068/ https://www.ncbi.nlm.nih.gov/pubmed/34713539 http://dx.doi.org/10.1111/dth.15180 |
Ejemplares similares
-
Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments
por: Steinhoff, Martin, et al.
Publicado: (2016) -
Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris
por: Pozdnyakov, Yuri M.
Publicado: (2018) -
New developments in the treatment of rosacea – role of once-daily ivermectin cream
por: Cardwell, Leah A, et al.
Publicado: (2016) -
Safety and efficacy of doxycycline in the treatment of rosacea
por: Valentín, Sheila, et al.
Publicado: (2009) -
Pharmacokinetics of Once‐Daily Extended‐Release Tacrolimus Tablets Versus Twice‐Daily Capsules in De Novo Liver Transplant
por: DuBay, Derek A., et al.
Publicado: (2019)